Company Filing History:
Years Active: 1989-1995
Title: Innovative Contributions of David C. Gust
Introduction
David C. Gust is a notable inventor based in Andover, MN, USA. With a remarkable portfolio of two patents, he has made significant contributions to the fields of electrocardiography and chemical sensing. His work continues to impact healthcare and safety, showcasing the importance of innovation in these critical areas.
Latest Patents
David C. Gust's latest patents include a "Sensor for peracetic acid-hydrogen peroxide solution" and a "Method and system for gathering electrocardiographic data." The electrocardiographic method reveals a novel approach where EKG data is collected by monitoring the difference in electrical potential at a minimum of three patient leads over an extended period of at least 15 seconds, ideally for equal time spans of 20 seconds each. The innovation demonstrates that a 60-second three-lead EKG data sample is sufficient for monitoring cardiac function and diagnosing various cardiac dysfunctions. Additionally, the system he developed allows for data storage and facilitates remote interpretation by trained individuals via phone lines, enhancing the accessibility of crucial cardiac data.
Career Highlights
Throughout his career, David has worked with several acclaimed companies, including Equimed Corporation and Minntech Corporation. His experiences in these organizations have surely provided him with the platform to innovate and refine his ideas, leading to the successful patents he holds today.
Collaborations
In his professional journey, David has collaborated with remarkable individuals, including Richard J. Olson and Louis C. Cosentino. These collaborations have likely enriched his work and contributed to the innovative spirit he embodies.
Conclusion
David C. Gust's contributions to the fields of electrocardiography and chemical sensing demonstrate the profound impact of targeted innovation. His patents provide valuable tools for healthcare professionals and enhance the efficacy of monitoring cardiac conditions. As he continues to innovate, David remains a key figure in the landscape of modern biomedical advancements.